Address
Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064
United States
Phone
Website
Business classification
VCID: 37787
Profile
Corporate information
Registration country
Official identities
US CIK 0000001800
Registration country
Official identities
US CIK 0000001800
Investment activity status
Active investor
Team
Current employees
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/icon-person.png?itok=8SSzz6Wf "[node:title] photo"){kind=icon}
|
Miles White | Responsibilities: Executive Officer |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Topera Inc |
United States | 29 Oct 2014 | Acquisition USD 250,000,000 (USD 250,000,000) deal size. Initial investment. Led the investment round. Active |
|
|
|
ViroPharma Inc Provider of life-saving medicines for life-threatening diseases. |
United States | 23 Jun 2014 | Acquisition USD 495,000,000 (USD 495,000,000) deal size. Initial investment. Led the investment round. Active |
|
|
|
CFR Pharmaceuticals |
15 May 2014 | Acquisition Initial investment. Led the investment round. Active |
||
|
|
IDEV Technologies Inc Developer of next generation medical devices for use in the interventional radiology, vascular surgery, and cardiology device marketplace. |
United States | 15 Jul 2013 | Acquisition USD 310,000,000 (USD 310,000,000) deal size. Initial investment. Led the investment round. Active |
|
|
OptiMedica Corp |
United States | 15 Jul 2013 | Acquisition USD 400,000,000 (USD 400,000,000) deal size. Initial investment. Led the investment round. Active |
|
|
|
Cardiac Concepts Inc Now known as Respicardia Inc |
United States | 1 Aug 2010 | Series C Initial investment. Round participant. Active |
|
|
|
Facet Biotech |
9 Mar 2010 | Acquisition USD 450,000,000 (USD 450,000,000) deal size. Initial investment. Round participant. Active |
||
|
|
Visiogen Inc A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss. |
United States | 3 Oct 2009 | Acquisition USD 400,000,000 (USD 400,000,000) deal size. Initial investment. Round participant. Active |
|
|
|
Solvay Pharmaceuticals |
28 Sep 2009 | Acquisition USD 6,600,000,000 (USD 6,600,000,000) deal size. Initial investment. Led the investment round. Active |
||
|
|
Evalve Inc |
United States | 11 Sep 2009 | Acquisition 410,000,000 (USD 410,000,000) deal size. Initial investment. Round participant. Active |
|
|
|
Evalve |
11 Sep 2009 | Acquisition USD 410,000,000 (USD 410,000,000) deal size. Initial investment. Led the investment round. Active |
||
|
|
Ibis Biosciences |
17 Dec 2008 | Acquisition USD 215,000,000 (USD 215,000,000) deal size. Initial investment. Led the investment round. Active |
||
|
|
Integrated Vascular Systems Inc Medical device company developing devices to treat congestive heart failure. |
United States | 26 Sep 2003 | Acquisition Initial investment. Round participant. Active |
|
|
|
Spinal Concepts Inc Designer of spinal fixation technology for the medical industry (implants). |
United States | 2 Jun 2003 | Acquisition 170,000,000 (USD 170,000,000) deal size. Initial investment. Round participant. Active |
|
|
|
Perclose Inc |
United States | 12 Jul 1999 | Acquisition USD 680,000,000 (USD 680,000,000) deal size. Initial investment. Round participant. Active |
|
|
|
Triangle Pharmaceuticals Inc Anti-viral and oncology licensing company. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Hydra Biosciences Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Icagen Inc Biopharmaceutical company developing small molecule therapeutics that target ion channels for treatment of a variety of diseases. |
United States | N/A Initial investment. Round participant. Active |
